language
Language
Englishchevron_right
attach_money
Currency
$USDchevron_right
dark_mode
Dark Mode
policy
Privacy Policy
gavel
Terms of Service
GLGL

$139.82

-2.59
arrow_drop_down1.82%
Market closed·update15 Jan 2026 21:00

$141.59

+1.77
arrow_drop_up1.27%
Post-market·update15 Jan 2026 23:21
Day's Range
139.495-143.94
52-week Range
109.38-147.83

Chart

Loading chart...

Performance

Key Stats

Next Earnings Date2026-02-04
Next Earnings TimeAfter Market Close
Volume359.77K
Average Volume 30d530.08K

AI GL Summary

Powered by LiveAI
💰
13.4
Valuation (P/E Ratio)
Reasonable valuation given TTM P/E ratio.
📈
0.095
EPS Growth (YoY)
Positive EPS growth year-over-year (calculated from 2023 vs. 2024 annual net income).
Show More 🔒

AI Scoreboard

Powered by LiveAI
🔒

Overall Analysis

Buy
78

Globe Life Inc. presents a strong fundamental profile with consistent profitability and a stable business model in the insurance sector. While valuation metrics are reasonable, its growth might be more moderate compared to high-growth tech sectors. Technicals show a generally positive trend but with some caution on short-term indicators.

Neutral to Positive

Thematic

65

Operating in the insurance and financial services sector, Globe Life benefits from stable demand for its products. Emerging trends like digital transformation in insurance and increased demand for financial security are supportive, but it doesn't ride major high-growth tech themes like AI or cloud computing.

Strong

Fundamental

85

Globe Life demonstrates strong financial health with healthy profit margins, consistent earnings growth, and a robust balance sheet. Its dividend yield is attractive for income-focused investors.

Neutral to Bullish

Technical

68

The stock has shown strong performance over the past year, trading above key moving averages. However, some short-term oscillators suggest it may be nearing overbought conditions, hinting at a potential for consolidation.

FactorScore
Insurance Sector Demand80
Digital Transformation in Insurance60
Financial Security & Stability75
Interest Rate Sensitivity50
Regulatory Landscape55
FactorScore
Valuation80
Profitability85
Growth70
Balance Sheet Health75
Cash Flow85
Dividend Yield70
FactorScore
Trend Analysis80
Momentum70
Volume Confirmation70
Support & Resistance60
Short-term Performance75

AI Investing Checklist

Powered by LiveAI
thumb_up

Bullish Points (7)

Valuation chevron_right

Attractive P/E Ratio

The Price-to-Earnings (P/E) ratio of 13.4 (TTM) is relatively low compared to historical averages and industry peers, suggesting potential undervaluation.

Earnings Performance chevron_right

Consistent EPS Growth

The company has consistently met or exceeded earnings per share (EPS) estimates in recent quarters, with a positive surprise percentage in most periods, indicating robust earnings power.

Show More 🔒
thumb_down

Bearish Points (7)

Valuation chevron_right

Increasing P/S Ratio

The Price-to-Sales (P/S) ratio has increased from 1.5 in 2021 to 2.0 in 2023, potentially indicating that the stock is becoming more expensive relative to its revenue.

Earnings Performance chevron_right

EPS Misses

There have been instances of the company missing EPS estimates (e.g., Q2 2025 estimate vs. reported), which could signal potential future earnings headwinds.

Show More 🔒

Calendar

July 2025

3

Ex-Dividend Date

August 2025

1

Next Dividend Date

October 2025

23

Next Earnings Date

EPS Est.
Revenue Est.

H: $4.45

A: $3.98

L: $3.46

H: 1.52B

A: 1.52B

L: 1.51B

Profile

Employees (FY)3.73K
ISINUS37959E1029
FIGI-

Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates through three segments: Life Insurance, Supplemental Health Insurance, and Investments. It offers whole, term, and other life insurance products; and Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products. The company sells its products through its direct-to-consumer division, exclusive agencies, and independent agents. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.

Seasonals

2025
2024
2023
2022
2021

Price Target

148.64 USD

The 39 analysts offering 1 year price forecasts for GL have a max estimate of 188.00 and a min estimate of 114.00.

Debt Level and Coverage

Debt
Free cash flow
Cash & equivalents

Financial Position Analysis

Assets
Liabilities

Ownership

Free Float shares
81.8M (99.15%)
Closely held shares
702K (0.85%)
82.5M
Free Float shares
81.8M (99.15%)
Closely held shares
702K (0.85%)

Capital Structure

Market cap
10.86B
Debt
2.74B
Minority interest
0.00
Cash & equivalents
165.32M
Enterprise value
13.43B

Valuation - Summary

Market Cap
10.9B
Net income
813M(7.49%)
Revenue
4.4B(40.55%)
10.9B
Market Cap
10.9B
Net income
813M(7.49%)
Revenue
4.4B(40.55%)
Price to earning ratio (P/E)13.40x
Price to sales ratio (P/S)2.50x

Valuation - Ratios

P/E
P/S

Revenue to Profit Conversion

Revenue
5.78B
COGS
5.78B
Gross Profit
0.00
OpEx
0.00
Operating Income
0.00
Other & Taxes
-1.07B
Net Income
1.07B

Balance Sheet

Total assets
Total liabilities
Liabilities to assets %

Income Statement

Revenue
Net Income
Net Margin

Cash Flow

Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Show More 🔒